MFP
AEGR

Michael F. Price’s Aegerion Pharmaceuticals AEGR Stock Holding History

Michael F. Price’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-240,000
Closed -$8.01M – 106
2014
Q3 		$8.01M Hold
240,000
– – 1% 32
2014
Q2 		$7.7M Buy
240,000
+40,000
+20% +$1.49M 0.94% 33
2014
Q1 		$9.24M Buy
+200,000
New +$11.7M 1.12% 32

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Michael F. Price's AEGR Position: Q4 2014 in Review

Michael F. Price sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2014, closing a stake of 240,000 shares — an estimated $8.01M sold.

Michael F. Price first reported a position in AEGR in Q1 2014 and held it in 3 quarters. The position peaked at $9.24M in Q1 2014. 95 funds tracked by Wall St. Rank hold AEGR as of Q4 2014.

  • Michael F. Price reported no remaining Aegerion Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Michael F. Price sold 240,000 Aegerion Pharmaceuticals shares in Q4 2014, an estimated $8.01M.
  • Michael F. Price first reported a position in Aegerion Pharmaceuticals in Q1 2014 and held it in 3 quarters.
  • Michael F. Price's Aegerion Pharmaceuticals position peaked at $9.24M in Q1 2014.
  • 95 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2014.

Based on Michael F. Price's 13F filing for Q4 2014, filed 17 Feb 2015.